A detailed history of Geode Capital Management, LLC transactions in Rx Sight, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 817,117 shares of RXST stock, worth $36.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
817,117
Previous 694,342 17.68%
Holding current value
$36.6 Million
Previous $41.8 Million 3.32%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$40.78 - $57.04 $5.01 Million - $7 Million
122,775 Added 17.68%
817,117 $40.4 Million
Q2 2024

Aug 09, 2024

BUY
$50.42 - $64.29 $5.98 Million - $7.63 Million
118,682 Added 20.62%
694,342 $41.8 Million
Q1 2024

May 13, 2024

BUY
$35.51 - $57.92 $609,103 - $993,501
17,153 Added 3.07%
575,660 $29.7 Million
Q4 2023

Feb 13, 2024

BUY
$20.91 - $40.9 $844,094 - $1.65 Million
40,368 Added 7.79%
558,507 $22.5 Million
Q3 2023

Nov 13, 2023

BUY
$27.05 - $33.37 $1.79 Million - $2.21 Million
66,320 Added 14.68%
518,139 $14.5 Million
Q2 2023

Aug 11, 2023

BUY
$16.37 - $28.9 $867,282 - $1.53 Million
52,980 Added 13.28%
451,819 $13 Million
Q1 2023

May 15, 2023

BUY
$12.58 - $16.68 $1.18 Million - $1.57 Million
93,869 Added 30.78%
398,839 $6.65 Million
Q4 2022

Feb 13, 2023

BUY
$9.93 - $14.2 $251,447 - $359,572
25,322 Added 9.05%
304,970 $3.86 Million
Q3 2022

Nov 14, 2022

BUY
$11.19 - $15.85 $580,593 - $822,377
51,885 Added 22.78%
279,648 $3.36 Million
Q2 2022

Aug 12, 2022

BUY
$10.61 - $16.66 $66,705 - $104,741
6,287 Added 2.84%
227,763 $3.21 Million
Q1 2022

May 13, 2022

BUY
$8.97 - $14.03 $892,012 - $1.4 Million
99,444 Added 81.49%
221,476 $2.74 Million
Q4 2021

Feb 11, 2022

BUY
$9.52 - $13.81 $394,642 - $572,479
41,454 Added 51.45%
122,032 $1.37 Million
Q3 2021

Nov 12, 2021

BUY
$11.85 - $17.32 $954,849 - $1.4 Million
80,578 New
80,578 $1.02 Million

Others Institutions Holding RXST

About RxSight, Inc.


  • Ticker RXST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 27,638,900
  • Market Cap $1.24B
  • Description
  • RxSight, Inc., a medical technology company, engages in the research and development, manufacture, and sale of light adjustable intraocular lenses (LAL) used in cataract surgery in the United States and internationally. It offers RxSight system that enables doctors to customize and enhance the visual acuity for patients after cataract surgery. T...
More about RXST
Track This Portfolio

Track Geode Capital Management, LLC Portfolio

Follow Geode Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.